Background: The importance of smoking in bronchial asthma has been thoroughly investigated. Although a high smoking rate has been recognized in Japan, there have been few studies of the relationship between active smoking and bronchial asthma, and little analysis of the gender difference in this relationship. The aims of this study were to examine the contribution of active smoking to asthma and to clarify any gender difference.
INTRODUCTION
Active cigarette smoking is common in adult asthma patients, and their prevalence rates are likely to be similar to the general population. 1 The current smok-ing rate among asthma patients ranges from 17% to 35% . [2] [3] [4] [5] [6] [7] [8] [9] Because the pathogeneses of bronchial asthma is thought to be inflammation of the bronchi that leads to bronchial hypersensitivity and bronchial airflow limitation , 10 the influence of smoking was T a b l e 1 Co n t e n t s o f t h e q u e s t i o n n a i r e u s e d f o r a s t h ma t i c p a t i e n t s i n t h i s s t u d y ( o r i g i n a l l y i n J a p a n e s e . ) brought to the attentions of these asthmatic stages. [11] [12] [13] The influence of smoking on the therapeutic response to corticosteroids has been reported. 14 However, it is important to study the clinical impli-cations of active smoking, and few such studies have been performed in Japan. It is well known that disease profiles and factors associated with diseases can vary by sex. In respiratory T a b l e 2 A d u l t b r o n c h i a l a s t h ma s e v e r i t y a s s e s s me n t c o mmi t t e e ' s s t a n d a r d s o f t h e J a p a n e s e S o c i e t y o f A l l e r g o lo g y S e v e r i t y o f s y mp t o ms f r e q u e n c y D ( D1 / D2 ) C B A mo d e r a t e mo d e r a t e s e v e r e s e v e r e 5 -7 / we e k mi l d mo d e r a t e mo d e r a t e s e v e r e 3 -4 / we e k mi l d mi l d mo d e r a t e s e v e r e 1 -2 / we e k diseases , gender differences of the bronchi have been reported . 15 Although cigarette smoking is thought to cause more respiratory symptoms and greater deterioration in lung function in women than in men, 16, 17 this is controversial. 18 In the management of bronchial asthma, some have reported that women are more affected by smoking than men . 19, 20 However, the gender difference with regard to the influence of active smoking on asthma patients in Japan is unclear , because Japan differs in race and lifestyle from the countries where such analyses were performed.
A questionnaire survey was conducted by the Niigata Asthma Treatment Study Group , taking these factors into consideration. Subjects from this survey were adult patients with bronchial asthma who visited medical institutions in the Niigata Prefecture, starting in 1998. The attending physicians of these patients were included in the survey. Based on this survey, we have reported the clinical characteristics of adult bronchial asthma patients, 21 the characteristics of elderly bronchial asthma patients 22 and changes in asthma management. 23 At the beginning of this survey , there were no questions about active cigarette smoking; these questions were added in 2000. In this paper, the analysis was based on results obtained from surveys conducted from 2000 onwards, to examine the relationship between asthma and active smoking , and any gender difference.
METHODS
The questionnaire used in this study was performed in Niigata Prefecture, Japan, under the Ethical Principles for Medical Research Involving Human Subjects, Declaration of Helsinki . The institutions involved were 32 large hospitals (200 beds or more), 24 small hospitals (< 200 beds) and 44 clinics (no beds). Eight thousand questionnaires were prepared and 3293 were answered (collection rate : 41.2%). The contents of the questionnaire are shown in Table 1 (originally in Japanese). The questionnaire was carried out over 2 months from September to October 2000. Subjects were recruited from adult patients (aged 16 years and over) with bronchial asthma who regularly visited the participating institutions for asthma management (typically once or twice per month) . They were recruited by their physician during a regular visit during the study period . The recruited patients were asked to complete the questionnaire by themselves (Table 1) . Therefore, the understanding of technical terms such as attack or unconscious (Table 1) depended upon individual patients
For an evaluation of asthma control, patients were asked about their mean peak expiratory flow value (PEFV) and the presence of asthma attacks during the two weeks prior to the questionnaire . The patients were also asked about their asthma during the year prior to the questionnaire by choosing 1 of 3 answers: few attacks seasonal attacks or frequent attacks
The questionnaire asked about asthmarelated symptoms in the two weeks prior to the questionnaire, including cough and sputum in the morning and at night, and sleep disturbance. The questionnaire also inquired about asthma-related emergencies , including ambulance use , emergency department visits and hospitalization , and life-threatening events including unconsciousness during asthma attacks, and attacks requiring respirator management, and asthma attacks induced by anti-inflammatoryagent (aspirin induced asthma) . The subjects were asked to answer yes or no to the following five questions:
Have you ever been hospitalized due to asthma
Have you ever been taken by ambulance or visited an emergency room due to an attack
Have you ever been placed on a respirator due to an asthma attack Have you ever been unconscious during an asthma attack and Have you ever had an attack induced by anti-inflammatory drugs including painkillers , antipyretics , or cold medicine
To evaluate problems with asthma management and treatment related to normal activity levels, the questionnaire asked patients about satisfaction in daily life. The subjects answered by choosing 1 of 5 answers: very satisfied fairly satisfied mediocre slightly unsatisfied and not satisfied
At the time that the patient completed their questionnaire, their physician was asked to supply details of current treatment, the type of asthma ( atopic or non-atopic, according to elevation of serum total IgE or significant detection of specific IgE for allergens), and the severity of asthma, using the adult bronchial asthma severity assessment committee's standards of the Japanese Society of Allergology. As shown in Table 2, severity was classified according to a combination of frequency and degree of attacks during the worst 4 weeks prior to the questionnaire. However, in cases of administration of corticosteroids , the total dosage of corticosteroids , including inhaled corticosteroids, can independently define the severity. A case was classified as severe with a dose of more T a b l e 3 -a B a c k g r o u n d a n d me d i c a t i o n i n ma l e p a t i e n t s c u r r e n t s mo k e r s ( n = 3 4 0 ) n o n -s mo k e r s ( n = 3 2 5 ) 3 4 7 + / -1 9 2 B r i n k ma n ' s i n d e x ( me a n + / -S D) 5 0 . 5 + / -1 6 . 6 5 1 . 6 + / -1 9 . 0 a g e ( me a n + / -S D) 1 6 . 6 + / -2 1 . 1 ＊ 1 5 . 0 + / -1 5 . 9 d u r a t i o n ( y e a r : me a n + / -S D) 7 0 . 3 / 2 2 . 1 ＊ Patients were classified into three groups : nonsmokers (NS), ex-smokers (ES) and current smokers (CS). The CS group was mainly compared with the NS group, because of varied duration of smoking and of cessation of smoking in the ES group
The results were expressed as arithmetic means T a b l e 4 -a P r e s e n c e o f a s t h ma a t t a c k s , p e a k f l o w v a l u e s , a s t h ma -r e l a t e d s y mp t o ms a n d s l e e p d i s t u r b a n c e i n ma l e p a t i e n t s d u r i n g t h e t wo we e k s p r i o r t o q u e s t i o n n a i r e c u r r e n t s mo k e r s ( n = 3 4 0 ) n o n -s mo k e r s ( n = 3 2 5 ) 4 0 . 0 3 2 . 6 P A ( %) 4 4 3 + / -1 3 9 ( n = 9 8 ) ＊＊＊ 4 7 3 + / -1 2 5 ( n = 1 2 2 ) P E F V ( mo r n i n g , me a n + / -S D) 4 5 3 + / -1 4 7 ( n = 9 4 ) ＊＊＊ 4 8 4 + / -1 2 8 ( n = 1 1 7 ) P E F V ( n i g h t , me a n + / -S D) 6 4 . 4 ＊＊＊ 4 5 . 5 A RS i n t h e mo r n i n g ( %) 2 4 . 7 ＊＊ 1 9 . 1 s p u t a i n t h e mo r n i n g ( %) 3 7 4 + / -8 3 ( n = 3 5 ) ＊＊ 3 2 8 + / -9 2 ( n = 3 9 6 ) P E F V ( mo r n i n g , me a n + / -S D) 3 8 7 + / -8 1 ( n = 3 4 ) ＊＊ 3 3 9 + / -9 1 ( n = 3 9 2 ) P E F V ( n i g h t , me a n + / -S D) 5 7 . 8 5 2 . 8 A RS i n t h e mo r n i n g ( %) 2 2 . 9 2 1 . 9 s p u t a i n t h e mo r n i n g ( %) 2 6 . 6 2 1 . 7 c o u g h i n t h e mo r n i n g ( %) 4 1 . 
RESULTS

PATIENT BACKGROUND AND DRUG MEDICA-TION
Patient background and medication usage in the CS and NS groups are summarized in Table 3 . In this study, 3293 patients responded. Of the male patients, 325 (22.0%) were classified as NS, 812 (57.0%) were classified as ES, and 340 ( 23.0%) were classified as CS. Of the female patients, 1132 (77.0%) were classified as NS, 229 (15.6%) were classified as ES and 109 
s e v e r i t y o f a s t h ma a t t a c k s i n t h i s t wo we e k s
A RS : a s t h ma -r e l a t e d s y mp t o ms (7.4%) were classified as CS. There was a marked difference in the distribution of active cigarette smoking between men and women. In male patients, the mean duration of asthma and the proportion of atopic asthma were significantly higher in the CS group than in the NS group, and the rate of inhaled corticosteroid (ICS) and oral sustained-release theophylline ( OSRT ) use was significantly lower in the CS group than in the NS group ( Table 3-a ) . In female patients, patient age and rate of oral corticosteroid use were significantly lower in the CS group than in the NS group, and the rate of ICS use was significantly higher in the CS group than in the NS group (Table 3-b ). There was a significant difference in disease severity between the CS group and the NS group in women, but not in men. There was a significantly higher prevalence of ambulance use and emergency department visits in the female CS group than in the female NS group. There was no significant difference in the Brinkman's index for men and women
ASTHMA CONTROL
The presence of asthma attacks , PEFV , asthmarelated symptoms, cough, sputum and sleep disturbance during the two weeks prior to the questionnaire, which reflect relatively short-term asthma control, are summarized in Table 4 . In men, PEFV was significantly lower, both in the morning and at night, in the CS group than in the NS group ( Table 5 , which indicates relatively long-term asthma control. There was a significant difference in long-term asthma control between the CS group and the NS group in men, but not in women (Tables 5-a, b). A significant difference in satisfaction in daily life was found between the CS group and the NS group in both men and women (Tables 6-a, b).
MULTIPLE REGRESSION ANALYSIS AND LO-GISTIC REGRESSION ANALYSIS ( 12 DEPEND-ENT VARIABLES AND 14 EXPLANATORY VARI-ABLES)
The results shown in Table 4 indicate that the susceptibility of asthma to active smoking may be different in men and women in our study. However, medications and background factors , which can influence control and symptoms of asthma, must be taken into consideration . Multiple regression analysis with a stepwise procedure for continuous data, and logistic regression analysis with a stepwise procedure for categorical data were performed. Table 7-a shows 14  explanatory variables , and Table 7-b shows 12 dependent variables used in this study.  Tables 8-a, b , c, d and e show the partially analyzed data. In men, active smoking contributed significantly to asthma-related symptoms in the morning (Table 8 a) and at night (Table 8-d ), cough and sputum in the morning (Tables 8-b , c) and sleep disturbance (Table 8-e). By contrast, there was no relationship between smoking and these asthma symptoms in women.
DISCUSSION
This study analyzed the results of a questionnaire survey in Niigata Prefecture conducted on 2000. In this study, the male CS group had a longer duration of asthma and a higher incidence of atopic asthma, and the CS group had lower rates of medication with ICS and OSRT than the NS group (Table 3 -a). This may influence asthma control -less medication in the male CS group could result in the poor control shown in Table 4 -a. However , regression analysis revealed that the use of OSRT and ICS did not contribute to asthma symptoms in men, except that OSRT did contribute to asthma-related symptoms in the morning. On the other hand, active smoking significantly contributed to asthma symptoms ( Table 8) , indicating that the male CS group tended to manifest more asthma symptoms , including cough , sputum and sleep disturbance, than the male NS group.
As summarized in Tables 3-b and 4-b, there were also some differences between the female CS group and the female NS group. When interpreting these results, there were several problems. The female CS group was much younger, had a lower rate of mild asthma, a lower incidence of oral corticosteroid use, and a higher incidence of ICS use than the female NS group . It is well known that PEFV decreases with age ; the female CS group was significantly younger than the female NS group, and had a higher PEFV ( Table 3-b) . Therefore, Table 4 -b may not exclude a contribution of smoking to asthma symptoms in the female CS group . However , regression analysis clearly showed no contribution of smoking to asthma symptoms in women. This apparently differs from the situation in men.
The finding of this study that there was a gender difference in susceptibility of asthma to active smoking was potentially a problem, because previous reports have showed that active smoking induced more respiratory symptoms, and a greater decrease in lung function , in women than in men . 16, 17 Women with asthma have been reported to be more affected by smoking than men. 19, 20 However, there are possible explanations for our result. Black male smokers have been reported to have a more marked decrease in lung function than black female smokers . 18 This T a b l e 8 -a Re g r e s s i o n a n a l y s i s o f a s t h ma r e l a t e d s y mp t o ms i n t h e mo r n i n g means that the previously reported susceptibility pattern is still controversial. Another is that these studies were performed outside Japan. Despite the high prevalence of smoking in Japan, the incidence of lung cancer has been lower in Japan than in Western countries ( the Japanese smoking paradox ), 24 indicating that the Japanese may also differ from other races in their susceptibility of asthma to active smoking. A recent study performed in Japan revealed fewer ( but not significantly fewer) effects of active smoking on female smokers than male smokers ; 9 this result was similar to our own, except that our study has clearly demonstrated a significant difference in susceptibility of asthma symptoms to smoking.
In other advanced countries, the current smoking rate among asthma patients ranges from 17% to 35%, with little gender difference. [2] [3] [4] [5] [6] [7] [8] [9] However, the current smoking rate among women in this study was lower T a b l e 8 -d Re g r e s s i o n a n a l y s i s o f a s t h ma r e l a t e d s y mp t o ms a t n i g h t than this (7.4%), although the Brinkman's Index was the same for the male and female CS groups ( Table 3 ). Because other lifestyle factors were not examined in this study , it is uncertain whether active smoking was independent of other lifestyle factors . When classification was performed according to smoking status, unexpected selection related to other factors in the Japanese female lifestyle may occur. Table 3-b showed a significant increase in the rate of experience of ambulance or ED in female CS group compared with female NS group, which may be related with this factor associated with Japanese female lifestyle. The Japanese lifestyle is now changing toward the Western lifestyle. Therefore further investigation is required This gender difference can influence the management of asthma. Stopping smoking is one of the most important steps in the management of asthmatic smokers, especially in men. It has been reported that an inhaled beta2 agonist, which can immediately improve asthma symptoms, improved ICS compliance. 25 This indicates that relief of asthma symptoms may be linked to improvement of other important factors in asthma management . The weaker linkage between smoking and asthma symptoms in women than in men could give unexpected results , such as restarting smoking . When female asthmatic smokers quit smoking , it may be important to inform them that stopping smoking will not always improve asthma symptoms. Thus, a gender-specific approach to smoking cessation is needed In summary , a questionnaire survey of adult patients with bronchial asthma, and their attending physicians in Niigata Prefecture , Japan , was analyzed with a focus on active smoking and gender differences . In the male CS group , there were more asthma-related symptoms, such as morning sputum and cough, and more severe sleep disturbance than those in the male NS group. In the female CS group, however, these symptoms were uncommon. A logistic and multiple regression analysis confirmed these significant differences between men and women. The gender differences in susceptibility of asthma to active smoking suggest the necessity of gender-specific strategies for smoking cessation, although further investigation is required
